Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Omega Healthcare InvestorsBSP:O2HI34 46 Price-to-Operating-Cash-Flow is 5.43 as of Aug. 09, 2026, which is 56% below its 10-year median of 12.41. GuruFocus rates BSP:O2HI34 with a GF Score™ of 46/100 and a GF Value™ of R$70.35 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 784 REITs companies, Omega Healthcare Investors ranks worse than 75.26% on this metric.
As of today (2026-08-09), Omega Healthcare Investors's share price is R$81.84.
Omega Healthcare Investors's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2026 was R$15.07. Hence, Omega Healthcare Investors's Price-to-Operating-Cash-Flow Ratio for today is 5.43.
The historical rank and industry rank for Omega Healthcare Investors's Price-to-Operating-Cash-Flow or its related term are showing as below:
BSP:O2HI34'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.75 Med: 12.41 Max: 18.19
Current: 17.04
During the past 13 years, Omega Healthcare Investors's highest Price-to-Operating-Cash-Flow Ratio was 18.19. The lowest was 8.75. And the median was 12.41.
BSP:O2HI34's Price-to-Operating-Cash-Flow is ranked worse than 75.26% of 784
companies
in the REITs industry
Industry Median: 11.815
vs BSP:O2HI34: 17.04
Omega Healthcare Investors's Cash Flow from Operations per share for the
three
months ended in Jun. 2026 was R$3.53.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2026 was R$15.07.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Omega Healthcare Investors was -1.00% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 4.00% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -1.30% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 0.20% per year.
During the past 13 years, Omega Healthcare Investors's highest 3-Year average Operating Cash Flow per Share Growth Rate was 48.50% per year. The lowest was -38.90% per year. And the median was 4.00% per year.
Omega Healthcare Investors Price-to-Operating-Cash-Flow Related Terms
Omega Healthcare Investors Price-to-Operating-Cash-Flow Historical Data
* Premium members only.
The historical data trend for Omega Healthcare Investors's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:O2HI34 vs DOC, AHR, CTRE: Price-to-Operating-Cash-Flow Comparison
For the REIT - Healthcare Facilities subindustry, Omega Healthcare Investors's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Omega Healthcare Investors Price-to-Operating-Cash-Flow vs REITs Industry
For the REITs industry and Real Estate sector, Omega Healthcare Investors's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Omega Healthcare Investors's Price-to-Operating-Cash-Flow falls into.
Omega Healthcare Investors's Share Price of today is R$81.84. Omega Healthcare Investors's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$15.07.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Price-to-Operating-Cash-Flow of 5.43 mean?
Omega Healthcare Investors (BSP:O2HI34) has a Price-to-Operating-Cash-Flow of 5.43 as of Aug. 09, 2026. Price-to-operating-cash-flow ratio is the ratio of share price to a company's per-share cash from operations. View historical data on Omega Healthcare Investors and its competitors. This is 56% below median its historical median of 12.41. Over the past decade, Omega Healthcare Investors' Price-to-Operating-Cash-Flow has ranged from 8.75 to 18.19. According to the industry distribution chart, Omega Healthcare Investors ranks #590 out of 784 companies in the REITs industry, placing it in the top 75.3%.
Is Omega Healthcare Investors' Price-to-Operating-Cash-Flow too high?
Omega Healthcare Investors' current Price-to-Operating-Cash-Flow of 5.43 is 56% below median its 10-year median of 12.41. Over the past 10 years, this metric has ranged from a low of 8.75 to a high of 18.19. The REITs industry median Price-to-Operating-Cash-Flow is 11.82. Omega Healthcare Investors' value of 5.43 is 54% below this industry median. Based on the distribution chart, Omega Healthcare Investors ranks #590 out of 784 companies in the REITs industry, which is in the bottom quartile relative to peers. Overall, Omega Healthcare Investors has a GF Score™ of 46/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Omega Healthcare Investors' Price-to-Operating-Cash-Flow compare to DOC and AHR?
According to the REITs industry distribution chart, Omega Healthcare Investors ranks #590 out of 784 companies for Price-to-Operating-Cash-Flow. This places Omega Healthcare Investors in the lower half of its industry. The industry median Price-to-Operating-Cash-Flow is 11.82. Omega Healthcare Investors' value of 5.43 is 54% below this benchmark. Historically, Omega Healthcare Investors' own Price-to-Operating-Cash-Flow has ranged from 8.75 to 18.19 over the past decade. While the company's 10-year median is 12.41 vs. the industry median of 11.82, Omega Healthcare Investors has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Operating-Cash-Flow for a REITs company?
The median Price-to-Operating-Cash-Flow among REITs companies is 11.82, based on 784 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Operating-Cash-Flow significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Operating-Cash-Flow should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Omega Healthcare Investors's current Price-to-Operating-Cash-Flow of 5.43 is 54% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Operating-Cash-Flow mean?
A high Price-to-Operating-Cash-Flow can signal that a stock is expensive relative to its fundamentals. Price-to-operating-cash-flow ratio is the ratio of share price to a company's per-share cash from operations. View historical data on Omega Healthcare Investors and its competitors. For the REITs industry, the median Price-to-Operating-Cash-Flow is 11.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omega Healthcare Investors's current Price-to-Operating-Cash-Flow is 5.43, which is 56% below median its own 10-year median of 12.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omega Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, Omega Healthcare Investors (BSP:O2HI34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$70.35, compared to a current price of R$81.84 — trading 16.3% above its estimated fair value. The current Price-to-Operating-Cash-Flow is 5.43, which is 56% below median its 10-year median of 12.41 and 54% below the REITs industry median of 11.82. Omega Healthcare Investors' overall GF Score™ is 46/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Operating-Cash-Flow calculated?
Price-to-Operating-Cash-Flow is calculated from a company's financial statements. For Omega Healthcare Investors (BSP:O2HI34), the current Price-to-Operating-Cash-Flow is 5.43 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Omega Healthcare Investors (BSP:O2HI34) Overvalued in 2026?
Based on GuruFocus' analysis, Omega Healthcare Investors stock appears to be overvalued.
The current stock price of R$81.84 is trading 16.3% above its estimated GF Value™ of R$70.35.
GuruFocus considers Omega Healthcare Investors to be Modestly Overvalued.
Key valuation signals for BSP:O2HI34:
Price-to-Operating-Cash-Flow: 5.43 (56% below median its 10-year median of 12.41)
GF Value™: R$70.35 vs. price of R$81.84 (16.3% above fair value)
Industry Position: 54% below the REITs median (#590 of 784)
No single metric tells the full story. See the BSP:O2HI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
46GF Score
Get the complete analysis for BSP:O2HI34
Price-to-Operating-Cash-Flow is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:O2HI34 has been successfully added to your 
